Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

L 767679

Known as: L 767,679, L-767,679, L-767679 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Most clinical trials with fibrinogen receptor antagonists (FRAs) have been associated with thrombocytopenia. This report… Expand
Is this relevant?
1999
1999
Most clinical trials with fibrinogen receptor antagonists (FRAs) have been associated with thrombocytopenia. This report… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1998
1998
The barriers to oral delivery of the hydrophilic zwitterion L-767, 679 (I) and its carboxyl ester prodrug L-775,318 (II) were… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1997
1997
The present study demonstrates the utility of an in vitro-in vivo correlative approach in the selection of an optimum prodrug… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 1
Is this relevant?
1997
1997
The pharmacokinetics of L-767,679, a potent fibrinogen receptor antagonist, were characterized following administration of its… Expand
Is this relevant?
1996
1996
The structure-activity relationship of a series of orally active glycoprotein IIb/IIIa antagonists containing a nitrogen… Expand
Is this relevant?